Supplement: CRISPR Shakes Up Tools and Tech
Innovators Are Developing More Precise DNA-Cutting and Single-Cell-Seeding Platforms
Streamlining the Peptide Synthesis Process
CEM Corporation Applies Advanced Microwave Technology
HPLC Summit Offers Expansive Biomolecular Views
High-Performance Liquid Chromatography (HPLC) Never Plateaus
The Scoop: CRISPR Patent Case Argued Before Appeals Court
Final Verdict Could Impact Future Research and Funding
For full access to this article login to GEN Select now.
Quantifying Downstream Capacity Crunch
Column Resins Are Implicated by Many Experts As the Source of Biomanufacturing's Woes
- In today’s biomanufacturing environment, downstream capacity has become a partial roadblock to nearly all CMOs (94%) and more than half (61%) of biotherapeutic developers. Extensive data from 434 biopharmaceutical manufacturers in 32 countries is summarized in BioPlan Associates’ just-released 5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.